Author:
Filho Antonio Carlos Bueno,Silveira Landulfo,Yanai Ana Leticia Sant’Anna,Fernandes Adriana Barrinha
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Center of Disease Control (CDC).
http://www.cdc.gov/ncbddd/sicklecell/data.html#references
Dec 2013
2. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute (2009) Disease and conditions index. Sickle cell anemia: who is at risk? Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute.
http://www.nhlbi.nih.gov/health/dci/Diseases/Sca/SCA_WhoIsAtRisk.html
. Dec 2013
3. Steinberg MH (2009) Genetic etiologies for phenotypic diversity in sickle cell anemia. Sci World J 9:46–67
4. Silva-Pinto AC, Angulo IL, Brunetta DM, Neves FIR, Bassi SC, De Santis GC, Covas DT (2013) Clinical and hematological effects of hydroxyurea therapy in sickle cell patients: a single-center experience in Brazil. Sao Paulo Med J 131:238–243
5. Salzano FM (1985) Incidence, effects and management of sickle cell disease in Brazil. Am J Pediatr Hematol Oncol 7:240–244
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献